The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention: A Randomised Controlled Clinical Trial

Table 3

Frequency distribution of syndrome factors in the different groups.

Syndrome factors	Before treatment (case (%))			1st week (case (%))			4th week (case (%))			12th week (case (%))
	Control	XFZY	SM	Control	XFZY	SM	Control	XFZY	SM	Control	XFZY	SM
Qi deficiency (case (%))	15 (50)	16 (57)	17 (57)	16 (53)	19 (63)	16 (53)	18 (64)	19 (63)	13 (44)	20 (71)	18 (62)	12 (41)
Blood stasis (case (%))	21 (70)	19 (63)	22 (73)	17 (57)	14 (47)	18 (60)	16 (57)	12 (41)	15 (51)	18 (64)	11 (37)	14 (48)
Yin deficiency (case (%))	12 (40)	11 (37)	10 (33)	13 (43)	12 (40)	11 (37)	14 (50)	12 (41)	10 (33)	16 (53)	13 (43)	10 (34)
Phlegm (case (%))	15 (50)	16 (53)	12 (40)	13 (43)	13 (43)	12 (40)	13 (46)	13 (44)	12 (41)	13 (46)	12 (41)	11 (38)
Qi stagnation (case (%))	13 (43)	12 (40)	12 (40)	12 (40)	10 (33)	11 (37)	11 (40)	8 (27)	9 (33)	13 (46)	7 (23)	10 (34)
Yang deficiency (case (%))	9 (27)	9 (30)	8 (27)	10 (33)	9 (30)	8 (27)	11 (37)	10 (33)	9 (26)	13 (46)	10 (34)	8 (27)